Recent clinical studies of the effects of lipid-modifying therapies

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Study 100%
• Low Density Lipoprotein Cholesterol 100%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 66%
• Clinical Trial 33%
• Inflammation 33%
• Atherosclerosis 33%
• Coronary Artery Disease 33%
• Cardiovascular Disease 33%
• Cardiovascular Risk 33%
• Statin (Protein) 33%
• High Density Lipoprotein Cholesterol 33%
• C Reactive Protein 33%
• Intervention Trial 33%
• Triacylglycerol 33%
• Nicotinic Acid 33%
• Antilipemic Agent 33%
• Ezetimibe 33%
• Fibric Acid Derivative 33%
• Cholesterol Ester Transfer Protein Inhibitor 33%
• Omega-3 Fatty Acid 33%
• Rosuvastatin 33%

Keyphrases

• Intensive Statin Therapy 33%